Understanding the impact of harm reduction program coverage on the incidence of blood borne viruses and related risk behaviours

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The provision of clean injecting equipment to people who inject drugs (PWID) is a crucial harm reduction intervention that has helped reduce the spread of blood borne viruses. The level to which PWID needs are adequately met is known as “coverage”, and it is the aim of this study to examine how variations in coverage impacts on PWID risk behaviours and health outcomes over time. This project will make important contributions to the evidence base for harm reduction and future implementation.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2017

Funding Scheme: Postgraduate Scholarships

Funding Amount: $86,073.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

access to health care | harm reduction | hepatitis C infection | incidence | injecting drug use